Study on clinical nursing path of hemodialysis patients
血液透析患者的临床护理路径研究

摘要

目的 分析予以血液透析治疗患者临床护理路径干预的应用价值。方法 研究开展于 2020.8， 终止时间为 2021.08，以在本阶段收治进行治疗的血液透析患者 70 例为研究对象，并根据随机分配原则分 为对照组（n=35，常规护理）和研究组（n=35，临床护理路径干预）。对比观察两组护理模式应用下护理 结局差异。结果 使用 ADL 量表、SF-36 量表和不良反应发生率评估两组护理模式应用结局，研究结果表 示研究组护理结局显著优于对照组，用（P＜0.05）代表组间差异明显，具有研究性。结论 血液透析患者 会有日常生活能力、生活质量低下、治疗过程中不良反应多等问题，采取临床护理路径干预有助于保障护 理效果。

Abstract

Objective To analyze the application value of clinical nursing pathway intervention for hemodialysis patients.
Methods The study was carried out in July, 2020 and ended in July, 2021. Seventy hemodialysis patients who were treated at this stage were taken as the research objects, and were randomly divided into control group (n=35, routine nursing) and research group (n=35, clinical nursing pathway intervention). Observe the difference of nursing outcomes between the two groups under the application of nursing mode.
Results ADL scale, SF-36 scale and the incidence of adverse reactions were used to evaluate the application outcomes of the two groups. The results showed that the nursing outcomes of the study group were significantly better than those of the control group, and the difference between the two groups was significant (P < 0.05), which was of research significance.
Conclusion   Hemodialysis patients will have problems such as daily living ability, low quality of life, and many adverse reactions in the treatment process, etc. Taking clinical nursing pathway intervention is helpful to ensure the nursing effect.